Board Change • May 20
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 4 non-independent directors. Chairman Lars Andersson was the last director to join the board, commencing their role in 2024. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Mar 03
Full year 2023 earnings released Full year 2023 results: Revenue: kr16.3m (up 19% from FY 2022). Net loss: kr16.6m (loss narrowed 68% from FY 2022). Board Change • Nov 16
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Chairman of the Board Ulf Lindsten was the last director to join the board, commencing their role in 2020. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Board Change • Apr 27
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Chairman of the Board Ulf Lindsten was the last director to join the board, commencing their role in 2020. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Feb 28
Full year 2021 earnings: Revenues in line with analyst expectations Full year 2021 results: Revenue: kr17.4m (down 37% from FY 2020). Net loss: kr22.3m (loss widened 88% from FY 2020). Revenue was in line with analyst estimates. Reported Earnings • Jun 05
Full year 2020 earnings released: kr0.36 loss per share (vs kr0.13 loss in FY 2019) The company reported a decent full year result with improved revenues, although losses increased and control over costs was weaker. Full year 2020 results: Revenue: kr27.7m (up 129% from FY 2019). Net loss: kr11.9m (loss widened 315% from FY 2019). Over the last 3 years on average, earnings per share has increased by 68% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth. お知らせ • Mar 12
Lightair AB (Publ) Receives an Order for Installation of LightAir Health+ LightAir has received an order for a large installation of air purifiers and virus inhibitors within its Professional Solutions segment. The American International School of Bucharest has ordered an air purification capacity of approximately 100,000 m3/h, with complementary antiviral technology corresponding to more than 300 classrooms. The deal was secured by LightAir's Romanian partner Wellnessist and confirms the potential of the LightAir Health+ offer, targeting offices and schools. LightAir Health+ is an innovative solution for air purification that consists of two complementary technologies. First, highly efficient air purifiers that lower the concentration of air pollutants through filtration. As much as 99.99% of traffic pollutants, viruses and ultrafine particles are removed from the indoor air. The second component consists of patented virus inhibitors, which actively seek out and destroy residual airborne viruses in the air. The two technologies together thus provide double protection against airborne viruses. お知らせ • Mar 03
Djurgården Hockey Installs Lightair Health+ Djurgården Hockey has chosen the LightAir Health+ air purification system for its elite-level men's, women's and junior ice hockey teams. The advanced air purification solution is now being installed and will cover meeting rooms, changing rooms and gym. The solution being installed at Djurgården Hockey is offered in Sweden primarily on a subscription basis, where clean air is provided as a service - including installation and ongoing maintenance. The service doesn't tie up capital and comes with a lifetime warranty regarding hardware functionality. お知らせ • Dec 20
LightAir AB (publ) has completed a Follow-on Equity Offering in the amount of SEK 27.2 million. LightAir AB (publ) has completed a Follow-on Equity Offering in the amount of SEK 27.2 million.
Security Name: Shares
Security Type: Common Stock
Transaction Features: Rights Offering お知らせ • Dec 17
LightAir Tests Air Purification Technology Against Coronavirus LightAir is initiating tests on coronavirus with a leading European virus research stitute. The tests will show h how well the Swedish company's IonFlow technology also prevents contact and airborne transmission of COVID19. A scientific study from Karolinska Institutet has previously shown that the technology inactivates influenza viruses immediately and continuously, and prevents airborne transmission. In the coming months, specific tests will be carried out to show how well IonFlow also neutralizes coronaviruses such as SARS-CoV-2, which causes the disease COVID19, and SARS-CoV-1, which causes the disease SARS. LightAirs patented IonFlow technology and its antiviral properties have previously been the subject of an extensive scientific research study, which was led by Professor Lennart Svensson, Linköping University Hospital, and Professor Hans Wigzell of Karolinska Institutet. The
study, published in June 2015 in Nature Scientific Reports, concludes that IonFlow technology prevents contact-based and airborne transmission of the viruses examined, which included those causing influenza and winter vomiting disease. Is New 90 Day High Low • Dec 16
New 90-day high: kr4.09 The company is up 20% from its price of kr3.42 on 17 September 2020. The Swedish market is up 4.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Consumer Durables industry, which is up 5.0% over the same period. Is New 90 Day High Low • Oct 16
New 90-day low: kr3.11 The company is down 11% from its price of kr3.50 on 17 July 2020. The Swedish market is up 7.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Consumer Durables industry, which is up 19% over the same period. 